Halozyme (HALO) Q4 2025 Earnings Call Transcript
Source: Motley Fool
2026-02-17 18:02:02 ET
Image source: The Motley Fool.
Feb. 17, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Halozyme Therapeutics Inc.
NASDAQ: HALO
HALO Trading
-0.01% G/L:
$67.22 Last:
547,646 Volume:
$66.80 Open:
HALO Latest News
March 06, 2026 08:00:00 am
U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
February 17, 2026 04:01:00 pm
HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE
HALO Stock Data
$9,572,395,800
114,186,687
0.24%
276
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
